419 related articles for article (PubMed ID: 23769398)
1. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.
Noh Y; Seo SW; Jeon S; Lee JM; Kim JH; Kim GH; Cho H; Yoon CW; Kim HJ; Ye BS; Kim ST; Choe YS; Lee KH; Kim JS; Ewers M; Weiner MW; Lee JH; Werring DJ; Kang DR; Kim CS; Na DL
J Alzheimers Dis; 2014; 40(4):877-86. PubMed ID: 24577457
[TBL] [Abstract][Full Text] [Related]
4. Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment.
Park JH; Seo SW; Kim C; Kim SH; Kim GH; Kim ST; Jeon S; Lee JM; Oh SJ; Kim JS; Choe YS; Lee KH; Shin JS; Kim CH; Noh Y; Cho H; Yoon CW; Kim HJ; Ye BS; Ewers M; Weiner MW; Lee JH; Werring DJ; Na DL
Neurobiol Aging; 2014 Jan; 35(1):254-60. PubMed ID: 23932881
[TBL] [Abstract][Full Text] [Related]
5. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
6. The Role of Cerebrovascular Disease in Amyloid Deposition.
Noh Y; Seo SW; Jeon S; Lee JM; Kim JS; Lee JH; Kim JH; Kim GH; Ye BS; Cho H; Kim HJ; Yoon CW; Choe YS; Lee KH; Weiner MW; Na DL
J Alzheimers Dis; 2016 Oct; 54(3):1015-1026. PubMed ID: 27567803
[TBL] [Abstract][Full Text] [Related]
7. Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.
Jung NY; Han JC; Ong YT; Cheung CY; Chen CP; Wong TY; Kim HJ; Kim YJ; Lee J; Lee JS; Jang YK; Kee C; Lee KH; Kim EJ; Seo SW; Na DL
J Neurol Sci; 2019 Jan; 396():94-101. PubMed ID: 30447606
[TBL] [Abstract][Full Text] [Related]
8. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
10. Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment.
Dao E; Hsiung GY; Sossi V; Jacova C; Tam R; Dinelle K; Best JR; Liu-Ambrose T
BMC Neurol; 2015 Oct; 15():197. PubMed ID: 26459220
[TBL] [Abstract][Full Text] [Related]
11. Blood viscosity in subcortical vascular mild cognitive impairment with versus without cerebral amyloid burden.
Noh HJ; Seo SW; Jeong Y; Park JE; Kim GH; Noh Y; Cho H; Kim HJ; Yoon CW; Ye BS; Werring DJ; Na DL
J Stroke Cerebrovasc Dis; 2014; 23(5):958-66. PubMed ID: 24589034
[TBL] [Abstract][Full Text] [Related]
12. Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia.
Ye BS; Seo SW; Kim JH; Kim GH; Cho H; Noh Y; Kim HJ; Yoon CW; Woo SY; Kim SH; Park HK; Kim ST; Choe YS; Lee KH; Kim JS; Oh SJ; Kim C; Weiner M; Lee JH; Na DL
Neurology; 2015 Nov; 85(19):1687-93. PubMed ID: 26468407
[TBL] [Abstract][Full Text] [Related]
13. Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions.
van Dijk EJ; Prins ND; Vermeer SE; Hofman A; van Duijn CM; Koudstaal PJ; Breteler MM
Ann Neurol; 2004 Apr; 55(4):570-5. PubMed ID: 15048897
[TBL] [Abstract][Full Text] [Related]
14. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI.
Chao LL; Decarli C; Kriger S; Truran D; Zhang Y; Laxamana J; Villeneuve S; Jagust WJ; Sanossian N; Mack WJ; Chui HC; Weiner MW
PLoS One; 2013; 8(6):e65175. PubMed ID: 23762308
[TBL] [Abstract][Full Text] [Related]
15. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
[TBL] [Abstract][Full Text] [Related]
16. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
[TBL] [Abstract][Full Text] [Related]
17. White matter hyperintensities predict amyloid increase in Alzheimer's disease.
Grimmer T; Faust M; Auer F; Alexopoulos P; Förstl H; Henriksen G; Perneczky R; Sorg C; Yousefi BH; Drzezga A; Kurz A
Neurobiol Aging; 2012 Dec; 33(12):2766-73. PubMed ID: 22410648
[TBL] [Abstract][Full Text] [Related]
18. Effects of amyloid and small vessel disease on white matter network disruption.
Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
[TBL] [Abstract][Full Text] [Related]
19. Early- vs late-onset subcortical vascular cognitive impairment.
Jang YK; Kwon H; Kim YJ; Jung NY; Lee JS; Lee J; Chin J; Im K; Jeon S; Lee JM; Seong JK; Kim JH; Kim S; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW; Kim HJ
Neurology; 2016 Feb; 86(6):527-34. PubMed ID: 26764026
[TBL] [Abstract][Full Text] [Related]
20. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
